BALTIMORE, Nov. 21, 2023 /PRNewswire/ MIRA Pharmaceuticals, Inc. , an innovative pre-clinical-stage pharmaceutical company, today announced it will host a shareholder update call on Tuesday,.
/PRNewswire/ MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), an innovative pre-clinical-stage pharmaceutical company, today announced.
Mira Pharma (MIRA) Reports Cognitive Enhancement with MIRA1a streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
– New Chemical Entity Aims to Provide New Treatments for Refractory Depression and Depression with Suicidal Thoughts –
– Ketamir-2 Is Being Developed As a Take Home Alternative to The.
Developing a first-in-class drug for inflammatory disease europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.